Maravai LifeSciences(MRVI) - 2022 Q4 - Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Debra Hart - Head of Investor Relations Carl Hull - Interim Chief Executive Officer Kevin Herde - Chief Financial Officer Trey Martin - President of Biologic Safety Testing Becky Buzzeo - Chief Commercial Officer Conference Call Participants Dan Leonard - Credit Suisse Matthew Sykes - Goldman Sachs Daniel Arias - Stifel Catherine Schulte - Robert W. Baird Tejas Savant - Mor ...